These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21435118)

  • 21. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
    Thom K; Male C; Falger J; Pabinger I
    Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor.
    Ashrani AA; Reding MT; Shet A; Osip J; Humar A; Lake JR; Key NS
    Haemophilia; 2004 Nov; 10(6):735-7. PubMed ID: 15569170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular hemorrhage in a patient with hemophilia.
    Kobayashi H; Honda Y
    Metab Ophthalmol; 1984-1985; 8(1):27-30. PubMed ID: 6441096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of hemorrhage in patients with hemophilia].
    Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055
    [No Abstract]   [Full Text] [Related]  

  • 25. Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.
    Valentino LA; Recht M; Dipaola J; Shapiro AD; Pipe SW; Ewing N; Urgo J; Bullock T; Simmons M; Deguzman C
    Haemophilia; 2009 May; 15(3):718-26. PubMed ID: 19298383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A.
    Lentz SR; Cerqueira M; Janic D; Kempton C; Matytsina I; Misgav M; Oldenburg J; Ozelo M; Recht M; Rosholm A; Savic A; Suzuki T; Tiede A; Santagostino E
    Haemophilia; 2016 Sep; 22(5):e445-9. PubMed ID: 27291066
    [No Abstract]   [Full Text] [Related]  

  • 27. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.
    Berntorp E; Figueiredo S; Futema L; Pock K; Knaub S; Walter O; Trawnicek L; Römisch J
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):577-83. PubMed ID: 20644466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylaxis in hemophilia].
    Ortega F; Martin-Villar J; Navarro JL
    Sangre (Barc); 1970; 15(3):355-61. PubMed ID: 5486763
    [No Abstract]   [Full Text] [Related]  

  • 29. Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery.
    Hay CR; Hellmann A; Dmoszynska A; Baglin T; O'Shaunessey D; Makris M; Shaikh-Zaidi R; Dash CH
    Haemophilia; 2011 May; 17(3):428-32. PubMed ID: 21371182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with prophylaxis in Sweden.
    Nilsson IM
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
    [No Abstract]   [Full Text] [Related]  

  • 31. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment and operative results for patients with transposition of the great arteries.
    Bastos P; de Leval M; Stark J
    Acta Med Port; 1980 Dec; Suppl 1():45-58. PubMed ID: 7223503
    [No Abstract]   [Full Text] [Related]  

  • 34. Arterial switch operation for a complex transposition of the great arteries in dextrocardia.
    Oppido G; Pace Napoleone C; Luca R; Gargiulo G
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):165-7. PubMed ID: 15621494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
    Björkman S; Folkesson A; Berntorp E
    Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single centre experience in circumcision of haemophilia patients: Izmir protocol.
    Yilmaz D; Akin M; Ay Y; Balkan C; Celik A; Ergün O; Kavakli K
    Haemophilia; 2010 Nov; 16(6):888-91. PubMed ID: 20491959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacokinetic model for factor VIII dosing during active haemorrhage in patients with haemophilia A.
    Ho AM; Dion P; Karmakar MK; Cheng G; Derrick JL; Chung DC; Tay BA
    Anaesthesia; 2001 Aug; 56(8):785-90. PubMed ID: 11493246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemophilia stress fractures--an increasing complication with better orthopaedic care.
    Carroll A; Nash MJ; Thachil J
    Haemophilia; 2013 May; 19(3):e178-80. PubMed ID: 23490261
    [No Abstract]   [Full Text] [Related]  

  • 40. Pregnancy and delivery in a woman with severe haemophilia A.
    Bodrozic JN; Miljic PS; Lekovic DR; Petronijevic MA; Antic DA; Mitrovic MM; Petronijevic-Vrzic SM; Djunic IS
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):496-499. PubMed ID: 28306626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.